Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jennifer Collins
Observed names:
J Collins,
Jennifer E. Collins
Institution:
Charleston Area Medical Center
Observed institution:
Charleston Area Medical Center
ORCID:
0000-0002-1195-4630
Observed ORCID:
0000-0002-1195-4630
OpenAlex ID:
A5136416503
A retrospective, real-world study of IV iron use to treat iron deficiency anemia during acute infection
2026
·
Haris Sohail
, Jennifer E. Collins
, et al.
·
Blood
·
13
Erratum to ‘Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases’ [Seminars in Oncology 53/1 (2026) 152436]
2026
·
Rafi Aibani
, Jennifer Collins
, et al.
·
Seminars in Oncology
·
1
PDF
Association of GLP-1 receptor agonist use with overall survival in patients with colorectal cancer and type 2 diabetes: A multicenter real-world study.
2026
·
Baqir Jafry
, Anahat Kaur
, et al.
·
Journal of Clinical Oncology
·
1
Immune checkpoint inhibitor–induced hyperthyroidism: Incidence, risk factors, and clinical outcomes in a real-world cohort study
2026
·
Baqir Jafry
, Farzeen Syed
, et al.
·
Journal of Oncology Pharmacy Practice
·
1
PDF
POSTER: CLL-1063: Temporal Trends and Demographic Disparities in Hematologic Malignancy Mortality in the United States
2026
·
Baqir Jafry
, Love Kumar
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CLL-1063: Temporal Trends and Demographic Disparities in Hematologic Malignancy Mortality in the United States
2026
·
Baqir Jafry
, Love Kumar
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MM-1145: Persistent Inequities in Multiple Myeloma Mortality Despite Therapeutic Advances in the United States
2026
·
Baqir Jafry
, Abbas Gain
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1145: Persistent Inequities in Multiple Myeloma Mortality Despite Therapeutic Advances in the United States
2026
·
Baqir Jafry
, Abbas Gain
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Safety of Immune Checkpoint Inhibitors in Patients with Solid Tumors and Hepatitis C: A TriNetX™ Real-World Analysis
2026
·
Muhammad Yousaf
, Jennifer Collins
, et al.
·
Oncology The American Medical Journal
PDF
Real-World Comparative Effectiveness of First-Line Enfortumab Vedotin Plus Pembrolizumab Versus Gemcitabine Plus Platinum in Metastatic Urothelial Carcinoma: A Propensity-Matched TriNetX Analysis
2026
·
Baqir Jafry
, Love Kumar
, et al.
·
Research Square
PDF
Comparative real-world outcomes of tarlatamab and lurbinectedin in relapsed extensive-stage small cell lung cancer.
2026
·
Daniyal Aziz Khan
, Haris Sohail
, et al.
·
Journal of Clinical Oncology
Real-world conditional survival analysis of blastic plasmacytoid dendritic cell neoplasm.
2026
·
Shreyas Shirodkar
, Jennifer Collins
·
Journal of Clinical Oncology
PDF
Survival impact of post-transplant tyrosine kinase inhibitor therapy in chronic myeloid leukemia.
2026
·
Muhammad Mujtaba Bhinder
, Haris Sohail
, et al.
·
Journal of Clinical Oncology
Association of prophylactic G-CSF use with survival outcomes in patients with aggressive B-cell lymphomas treated with R-CHOP.
2026
·
Daniyal Aziz Khan
, Haris Sohail
, et al.
·
Journal of Clinical Oncology
Immune-related thyroid dysfunction and overall survival in metastatic colorectal cancer treated with pembrolizumab: A real-world TriNetX analysis.
2026
·
Baqir Jafry
, Farzeen Fatma Syed
, et al.
·
Journal of Clinical Oncology
Early vs delayed bone-modifying agent initiation and zoledronic acid vs denosumab in newly diagnosed multiple myeloma.
2026
·
Farzeen Fatma Syed
, Saad Javaid
, et al.
·
Journal of Clinical Oncology
Statin exposure and clinical outcomes in metastatic prostate cancer: A propensity-matched TriNetX cohort study.
2026
·
Umar Khan Bazai
, Farzeen Fatma Syed
, et al.
·
Journal of Clinical Oncology
Cigarette smoking on outcomes with osimertinib in EGFR -mutated non–small cell lung cancer: A real-world analysis.
2026
·
Mohammad Alamgir
, Muhammad Yousaf
, et al.
·
Journal of Clinical Oncology
Timing of adjuvant nivolumab and survival outcomes in bladder cancer: A real-world analysis.
2026
·
Kok Hoe Chan
, Muhammad Yousaf
, et al.
·
Journal of Clinical Oncology
Adjuvant nivolumab compared with platinum-based chemotherapy in bladder cancer: A real-world study.
2026
·
Muhammad Yousaf
, Yashan Thakkar
, et al.
·
Journal of Clinical Oncology
PDF
Stage-specific comparative effectiveness of locoregional therapies in early-stage hepatocellular carcinoma: A global real-world analysis.
2026
·
Love Kumar
, Jennifer Collins
, et al.
·
Journal of Clinical Oncology
Comparative outcomes of leukapheresis and pharmacologic cytoreduction in hyperleukocytosis.
2026
·
Rafi Aibani
, Haris Sohail
, et al.
·
Journal of Clinical Oncology
Real-world overall survival with mirvetuximab soravtansine compared with chemotherapy after multiple lines of platinum therapy in gynecologic cancers.
2026
·
Courtney Nail
, Jennifer Collins
, et al.
·
Journal of Clinical Oncology
PDF
Beta-blocker use at immune checkpoint inhibitor initiation and survival in advanced solid tumors: A multi-institutional real-world cohort study.
2026
·
Farzeen Fatma Syed
, Baqir Jafry
, et al.
·
Journal of Clinical Oncology
Real-world comparative outcomes of including levetiracetam with standard treatment in glioblastoma multiforme: A multi-center retrospective cohort study.
2026
·
Shreyas Shirodkar
, Farzeen Fatma Syed
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
36
Citation count:
16
H-index:
1
I10-index:
1
Year
Topic
Type